Intermedin 17-47 does not function as a full intermedin antagonist within the central nervous system or pituitary

Peptides

Volumn 28, Issue 11, 2007, Pages 2171-2178

  White, Meghan M ^a   Samson, Willis K ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenomedullin; Blood pressure; Calcitonin gene related peptide; Food intake; Intermedin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INTERMEDIN; INTERMEDIN DERIVATIVE; INTERMEDIN INHIBITING FACTOR; INTERMEDIN[17-47]; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; FLUID INTAKE; FOOD INTAKE; GROWTH HORMONE RELEASE; HEART RATE; HORMONAL REGULATION; HYPOPHYSIS; HYPOPHYSIS CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENOMEDULLIN; ANIMALS; BLOOD PRESSURE; CELL LINE; CENTRAL NERVOUS SYSTEM; DRINKING; EATING; GROWTH HORMONE; HEART RATE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE;

RATTUS;

EID: 35348929287     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.09.001     Document Type: Article

References (27)

1. Caron K.M., and Smithies O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci USA 98 (2001) 615-619
2. Chang C.L., Roh J., Park J., Klein C., Cushman N., Haberberger R.V., et al. Intermedin functions as a pituitary paracrine factor regulating prolactin release. Mol Endocrinol 19 (2005) 2824-2838
3. Charles C.J., Rademaker M.T., and Richards A.M. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in normal conscious sheep. Endocrinology 147 (2006) 1871-1877
4. Chauhan M., Yallampalli U., Reed L., and Yallampalli C. Adrenomedullin 2 antagonist infusion to rats during midgestation causes fetoplacental growth restriction through apoptosis. Biol Reprod 75 (2006) 940-947
5. Chen L., Kis B., Hashimoto H., Busija B.W., Takei Y., Yamashita, et al. Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro. Brain Res 1086 (2006) 42-49
6. Dackor R.T., Fritz-Six K., Dunworth W.P., Gibbons C.L., Smithies O., and Caron K.M. Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 26 (2006) 2511-2518
7. Dong F., Taylor M.M., Samson W.K., and Ren J. Intermedin (adrenomedullin 2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes. J Appl Physiol 101 (2006) 778-784
8. Fujisawa Y., Nagai Y., Miyatake A., Miura K., Shoukouji T., Nishiyama A., et al. Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats. Am J Physiol 290 (2006) H1120-H1127
9. Fujisawa Y., Nagai Y., Miyatake A., Takei Y., Miura K., Shoukouji T., et al. Renal effects of a new member of adrenomedullin family, adrenomedullin 2, in rats. Eur J Pharmacol 497 (2004) 75-80
10. Hashimoto H., Hyodo S., Kawasaki M., Mera T., Chen L., Soya A., et al. Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats. Am J Physiol 289 (2005) E753-E761
11. Hashimoto H., Hyodo S., Kawasaki M., Shibata M., Saito T., Suzuki H., et al. Adrenomedullin 2 (AM2)/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in rats. Peptides 28 (2007) 1104-1112
12. Hay D.L., Christopoulos G., Christopoulos A., Poyner D.R., and Sexton P.M. Pharmacological discrimination of calcitonin receptor: receptor-activity-modifying protein complexes. Mol Pharmacol 67 (2005) 1655-1665
13. Hay D.L., Conner A.C., Howitt S.G., Smith D.M., and Poyner D.R. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22 (2003) 105-113
14. Husmann K., Born W., Fishcer J.A., and Muff R. Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. Biochem Pharmacol 66 (2003) 2107-2115
15. Kandilci H.B., Gumusel B., Wasserman A., Witriol N., and Lippton H. Intermedin/adrenomedullin 2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides 27 (2006) 1390-1396
16. Li M., Yee D., Magnuson T.R., Smithies O., and Caron K.M. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 116 (2006) 2653-2662
17. Ogoshi M., Inoue K., and Takei Y. Identification of a novel adrenomedullin gene family in teleost fish. Biochem Biophys Res Commun 311 (2003) 1072-1077
18. Ren Y.S., Yang J.H., Zhang J., Pan C.S., Yang J., Zhao J., et al. Intermedin 1-53 in central nervous system elevates arterial blood pressure in rats. Peptides 27 (2006) 74-79
19. Roh J., Chang C.L., Bhalla A., Klein C., and Hsu S.Y.T. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor-activity-modifying protein receptor complex. J Biol Chem 279 (2004) 7264-7274
20. Samson W.K., Murphy T.C., and Resch Z.T. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am J Physiol 274 (1998) R1505-R1509
21. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y., et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104 (2001) 1964-1971
22. Takahashi K., Kikuchi K., Maruyama Y., Urabe T., Nakajima K., Sasano H., et al. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart, and kidney. Peptides 27 (2006) 1383-1389
23. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., and Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556 (2004) 53-58
24. Taylor M.M., Bagley S.L., and Samson W.K. Intermedin/Adrenomedullin 2 acts within the central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol 288 (2005) R919-R927
25. Taylor M.M., Bagley S.L., and Samson W.K. Intermedin/Adrenomedullin 2 inhibits growth hormone release from cultured, primary anterior pituitary cells. Endocrinology 147 (2006) 859-864
26. Taylor M.M., and Samson W.K. Stress hormone secretion is altered by central administration of intermedin/adrenomedullin 2. Brain Res 1045 (2005) 199-205
27. Yang J.H., Qi Y.F., Jai Y.X., Pan C.S., Zhao J., Yang J., et al. Protective effects of intermedin/adrenomedullin 2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 26 (2005) 501-507